Upgrade to SI Premium - Free Trial

Jaguar Health explores strategic alternatives amid rare disease NDA push

June 22, 2026 9:00 AM
Jaguar Health, Inc. (NASDAQ: JAGX) said its Board of Directors has begun a process to explore strategic alternatives, including potential ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Mergers and Acquisitions